Inzy stock forecast.

Find the latest MAIA Biotechnology, Inc. (MAIA) stock quote, history, news and other vital information to help you with your stock trading and investing.

Inzy stock forecast. Things To Know About Inzy stock forecast.

Find out why INZY stock is a Hold. ... In a pre-revenue phase, evident by the consistent zero sales forecast, their growth is underpinned by the developmental stage of their drug, INZ-701 ...2 days ago · The latest Incyte stock prices, stock quotes, news, and INCY history to help you invest and trade smarter. ... The 51 analysts offering price forecasts for Incyte have a median target of 82.02 ... Inozyme Pharma falls after updates to rare disease program. Jul. 26, 2023 10:24 AM ET Inozyme Pharma, Inc. (INZY) By: Dulan Lokuwithana, SA News Editor. mphillips007. Inozyme Pharma ( NASDAQ: INZY ...View live Inozyme Pharma, Inc. chart to track its stock's price action. Find market predictions, INZY financials and market news. Search. Products; Community; Markets; News; ... Market closed Market closed. No trades. See on Supercharts. Overview . News Ideas Financials Technicals Forecast . INZY chart. Today 6.22% 5 days 20.55% 1 …

Upgrade to Premium to see how . INZY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks. Try It for Just $1. ... Inozyme Pharma 's …

Find the latest MEI Pharma, Inc. (MEIP) stock quote, history, news and other vital information to help you with your stock trading and investing.

Nasdaq Futures 16,054.50 +30.75(+0.19%) Russell 2000 Futures 1,807.30 +1.50(+0.08%) Crude Oil 77.85 -0.01(-0.01%) Gold 2,065.80 -1.30(-0.06%) Inozyme Pharma, Inc. (INZY) …Nasdaq Futures -44.75(-0.28%) Russell 2000 Futures 1,798.80 -12.20(-0.67%) Crude Oil 74.30 -1.24(-1.64%) Gold 2,013.20 +10.20(+0.51%) Inozyme Pharma, Inc. (INZY) NasdaqGS - NasdaqGS Real Time...Their INZY share price targets range from $6.00 to $23.00. On average, they predict the company's stock price to reach $15.00 in the next year. This suggests a possible upside of 289.6% from the stock's current price. View analysts price targets for INZY or view top-rated stocks among Wall Street analysts.Target values for the price of one Incyte share for Jan 2025. The weighted average target price per Incyte share in Jan 2025 is: 59.50. In Jan, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 7.054% volatility is expected. Pessimistic target level: 56.44. Optimistic target level: 60.73.We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...

Find the latest Incyte Corporation (INCY) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance

Inozyme Pharma, Inc. Common Stock (INZY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Advanced Charting News Inozyme Pharma Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-1.58 Market Cap $189.51 M …Inozyme Pharma's earnings are forecast to decline at 9.3% per annum while its annual revenue is expected to grow at 95.9% per year. EPS is expected to grow by 5.5% per annum.Find the latest SciSparc Ltd. (SPRC) stock quote, history, news and other vital information to help you with your stock trading and investing.Symbol Lookup from Yahoo Finance. Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance.Find the latest Vaxart, Inc. (VXRT) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Fangdd Network Group Ltd. (DUO) stock quote, history, news and other vital information to help you with your stock trading and investing.60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.

Find the latest Spyre Therapeutics, Inc. (AGLE) stock quote, history, news and other vital information to help you with your stock trading and investing.Earnings Date. Feb 05, 2024 - Feb 09, 2024. Forward Dividend & Yield. N/A (N/A) Ex-Dividend Date. N/A. 1y Target Est. 74.41. Fair Value is the appropriate price for the shares of a company, based ...500. Check out the ideas and forecasts on stocks from top authors of our community. They share predictions and technical outlook of the market to find trending stocks of different countries: India, USA, UK, Japan, etc. Join our financial community to start learning more about the markets. — India.What is the current Price Target and Forecast for Inozyme Pharma (INZY) Inozyme Pharma (INZY) (Delayed Data from NSDQ) $3.93 USD +0.23 (6.22%) Updated Nov 24, 2023 01:00 PM ET After-Market:...Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...Discover historical prices for INZY stock on Yahoo Finance. View daily, weekly or monthly format back to when Inozyme Pharma, Inc. stock was issued.

Find the latest eFFECTOR Therapeutics, Inc. (EFTR) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 13, 2023 · Inozyme Pharma's earnings are forecast to decline at 9.3% per annum while its annual revenue is expected to grow at 95.9% per year. EPS is expected to grow by 5.5% per annum.

Inozyme Pharma, Inc. Common Stock (INZY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.NVVE | Complete Nuvve Holding Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.View live Inozyme Pharma, Inc. chart to track its stock's ... View live Inozyme Pharma, Inc. chart to track its stock's price action. Find market predictions, INZY financials and …Nov 29, 2023 · Their INZY share price targets range from $6.00 to $23.00. On average, they predict the company's stock price to reach $15.00 in the next year. This suggests a possible upside of 289.6% from the stock's current price. View analysts price targets for INZY or view top-rated stocks among Wall Street analysts. View the latest Incyte Corp. (INCY) stock price, news, historical charts, analyst ratings and financial information from WSJ.Dec 1, 2023 · View Inozyme Pharma, Inc INZY investment & stock information. Get the latest Inozyme Pharma, Inc INZY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. INZY Stock Overview. Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases in the United States. ... Earnings are forecast to decline by an average of 9.3% per year for the next 3 years. Shareholders …Open $1.8900. Day Range 1.8200 - 1.9297. 52 Week Range 0.5800 - 6.7700. Market Cap $296.38M. Shares Outstanding 156.82M. Public Float 46.42M. Beta 0.48. Rev. per Employee $238.76K. P/E Ratio N/A.Open $1.8900. Day Range 1.8200 - 1.9297. 52 Week Range 0.5800 - 6.7700. Market Cap $296.38M. Shares Outstanding 156.82M. Public Float 46.42M. Beta 0.48. Rev. per Employee $238.76K. P/E Ratio N/A.

ARQT | Complete Arcutis Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Incyte Corp have a median target of 71.00, with a high estimate of 93.00 and a low estimate of 58.00. The median ...

Find the latest Tantech Holdings Ltd (TANH) stock quote, history, news and other vital information to help you with your stock trading and investing.Incyte Corp Revenue Forecast for 2023 - 2025 - 2030. Incyte Corp's Revenue has seen impressive growth In the last three years, rising from $2.16B to $3.39B – a growth of 57.25%. In the next year, analysts believe that Revenue will reach $3.93B – an increase of 15.71%. For the next eight years, the forecast is for Revenue to grow by 16.18%.According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy. Analyst Consensus: Strong Buy. Target Low Average Median High; Price: $116: $170.76: …Recently. Price. 3.700. -3.39%. Webull offers INZY Ent Holdg (INZY) historical stock prices, in-depth market analysis, NASDAQ: INZY real-time stock quote data, in-depth charts, free INZY options chain data, and a fully built financial calendar to help you invest smart. Buy INZY stock at Webull.Inozyme Pharma Inc (INZY) stock has fallen -6.11% while the S&P 500 is higher by 0.28% as of 3:14 PM on Monday, Apr 3. INZY is down -$0.35 from the previous closing price of $5.73 on volume of 1,192,651 shares. Over the past year the S&P 500 is down -10.08% while INZY is higher by 25.12%. INZY lost -$1.78 per share in the over the …Nov 24, 2023 · INZY Signals & Forecast The Inozyme Pharma, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. Dec 1, 2023 · 19 Wall Street analysts have issued 1-year price objectives for Incyte's stock. Their INCY share price targets range from $61.00 to $100.00. On average, they expect the company's share price to reach $79.94 in the next year. This suggests a possible upside of 48.0% from the stock's current price. Find the latest Phathom Pharmaceuticals, Inc. (PHAT) stock quote, history, news and other vital information to help you with your stock trading and investing.Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level. Try it Free. Find the latest Incyte Corporation (INCY) stock forecast based ...Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.

TipRanks | Stock Market Research, News and Analyst Forecasts ... In this article, we answer “what is sales forecasting?” by breaking down its objectives, owners, methods, and best practices. Sales | What is REVIEWED BY: Jess Pingrey Jess served on the founding team of a successful B2B startup and has use...Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $12.95B. -12.7%. Market Cap / Employee. The market cap of a ...Instagram:https://instagram. flexible spending account vendorsbest bank in alaskalargest european banksromanee conti price Website. 2015. 56. Doug Treco. https://www.inozyme.com. Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases in the United States. The company’s lead product candidate is INZ-701, a soluble, recombinant, genetically ...Find the latest Bullfrog AI Holdings, Inc. (BFRG) stock quote, history, news and other vital information to help you with your stock trading and investing. best stock alert appstocks compare Nov 29, 2023 · See the latest Incyte Corp stock price (INCY:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Nov 30, 2022 · Find the latest Incyte Corporation (INCY) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance oih etf Mar. 23, 2023, 11:25 AM. Needham analyst Joseph Stringer reiterated a Buy rating on Inozyme Pharma ( INZY – Research Report) today and set a price target of $23.00. The company’s shares opened ...Mar 23, 2023 · Analyst Price Forecast Suggests 489.65% Upside As of March 24, 2023, the average one-year price target for Inozyme Pharma is $19.46. The forecasts range from a low of $4.54 to a high of $42.00. Find the latest Dogecoin USD (DOGE-USD) price quote, history, news and other vital information to help you with your cryptocurrency trading and investing.